{"_canonicalization":{"envelope_id":"axm_ + sha256(envelope minus {signature, axiom_id, anchors})","envelope_signature":"ed25519(envelope minus {signature, axiom_id})","json":"sort_keys=True, separators=(',',':'), ensure_ascii=False, allow_nan=False, utf-8","leaf_hash":"sha256(0x00 || canonical_json(envelope_full))","seal_signature":"ed25519(seal minus {signature, sig_algorithm})"},"axiom_id":"axm_635a5b0c4183d7cd5aa33a2141db19633c90d6a597626bd6e9137b28f7ced1f3","bitcoin_anchor":{"bitcoin_attestations":[],"calendar_attestations":[],"ots_url":"","stamped_at":"","status":"pending_next_stamp"},"envelope":{"anchors":[{"chain":"crovia.axiom_graph","height":0,"merkle_proof":"spider_vendor_press_v1","root_at_anchor":"spider_vendor_press_v1"}],"axiom_id":"axm_635a5b0c4183d7cd5aa33a2141db19633c90d6a597626bd6e9137b28f7ced1f3","axiom_type":"AX.OBS","body":{"axiom_subtype":"news.vendor_press.v1","category":"news","fingerprint":"227a66c0c9341f35e17b1b53868cdadad413b630724dae0eb159c41505bbb248","published":"Thu, 04 Jun 2026 00:00:00 -0400","receipt_hash":"227a66c0c9341f35e17b1b53868cdadad413b630724dae0eb159c41505bbb248","schema":"spider.news.vendor_press.v1","spider":"vendor_press","spider_record":{"axiom_subtype":"news.vendor_press.v1","category":"news","decision_hint":"POSITIVE","envelope_target":"AX.OBS","fingerprint":"227a66c0c9341f35e17b1b53868cdadad413b630724dae0eb159c41505bbb248","observed_at":"2026-06-04T04:43:08.243501Z","parent_run_hash":"298818240313a3c9ce3ace3750dbf55845013dc3bc59aeced6331eccefdb61ac","published":"Thu, 04 Jun 2026 00:00:00 -0400","runtime_version":"0.1.0","schema":"spider.news.vendor_press.v1","source_status":200,"source_url":"https://export.arxiv.org/rss/cs.AI","spider":"vendor_press","summary_excerpt":"arXiv:2506.10912v4 Announce Type: replace \nAbstract: Toxicity remains a leading cause of early-stage drug development failure. Despite advances in molecular design and property prediction, the task of molecular toxicity repair, generating structurally valid molecular alternatives with reduced toxicity, has not yet been systematically defined or benchmarked. To fill this gap, we introduce ToxiMol, the first benchmark task for general-purpose Multimodal Large Language Models (MLLMs) focused on molecular toxicity repair. We construct a standardized dataset covering 11 primary tasks and 660 representative toxic molecules spanning diverse mechanisms and granularities. We design a prompt annotation pipeline with mechanism-aware and task-adaptive capabilities, informed by expert toxicological knowledge. In parallel, we propose an automated evaluation framework, ToxiEval, which integrates toxicity endpoint prediction, synthetic accessibility, drug-likeness, and structural similarity into a hig","title":"Breaking Bad Molecules: Are MLLMs Ready for Structure-Level Molecular Detoxification?","url":"https://arxiv.org/abs/2506.10912","vendor":"arxiv_cs_ai"},"summary":"arXiv:2506.10912v4 Announce Type: replace \nAbstract: Toxicity remains a leading cause of early-stage drug development failure. Despite advances in molecular design and property prediction, the task of molecular toxicity repair, generating structurally valid molecular alternatives with reduced toxicity, has not yet been systematically defined or benchmarked. To fill this gap, we introduce ToxiMol, the first benchmark task for general-purpose Multimodal Large Language Models (MLLMs) focused on molecular toxicity repair. We construct a standardized dataset covering 11 primary tasks and 660 representative toxic molecules spanning diverse mechanisms and granularities. We design a prompt annotation pipeline with mechanism-aware and task-adaptive capabilities, informed by expert toxicological knowledge. In parallel, we propose an automated evaluation framework, ToxiEval, which integrates toxicity endpoint prediction, synthetic accessibility, drug-likeness, and structural similarity into a hig","title":"Breaking Bad Molecules: Are MLLMs Ready for Structure-Level Molecular Detoxification?","vendor":"arxiv_cs_ai"},"confidence":{"method":"deterministic"},"decision":"POSITIVE","issued_at":"2026-06-04T04:43:08Z","notes":"Spider vendor_press (news) news.vendor_press.v1","object":{"captured_by":"crovia.spider.vendor_press","primary_source_url":"https://arxiv.org/abs/2506.10912"},"predecessors":[],"schema":"crovia.axiom.v1","signature":"ed25519:0549cc356f0d37efa3ea419d4ab6184398b7b2cae01aa0a34b9065a4c52d0302092b32d9de80e5b61dad9504889eab3e218143089e3ddeb52e6e1307b7fdef04","signer":"crovia.substrate","subject":{"observed_at":"2026-06-04T04:43:08Z","source_collector":"spider:vendor_press","target_id":"https://arxiv.org/abs/2506.10912"},"tsa":{"authority":"crovia.substrate.bootstrap","rfc3161_token":"{\"kind\":\"crovia.bootstrap.tsa\",\"source_jsonl\":\"/opt/crovia/spider/data/news/vendor_press_v1.jsonl\",\"source_seal_merkle_root\":\"spider_vendor_press_v1\",\"upgrade_path\":\"Sessione H \\u2014 OpenTimestamps weekly anchor\"}"},"zk_mode":"clear","zk_proof":null},"ledger":{"leaf_hash":"207f04e9cb624588312d85eed37cef6dce43ecfb02566c2eea4ae0ef07f59d33","leaf_index":212761,"ledger_path":"/opt/crovia/substrate/axiom_ledger.jsonl"},"merkle_proof":{"hash_alg":"sha256","leaf_prefix":"0x00","node_prefix":"0x01","odd_leaf_rule":"duplicate_last","path":[{"sibling":"ab2792620bc2aac152d6a22840541843b3b1c6bb61371ce17c40d16b9475182c","side":"left"},{"sibling":"c8240a94bd97e5dfbd9d9c9fa1e6a6aa6a5b468076c73bce0f10acba75176db0","side":"right"},{"sibling":"6e4c497dca91355f56e5a5c5da7ae97fada6901cf4f26aa5569ddec7b008ef76","side":"right"},{"sibling":"56444f6a01cfe751accf57a68c4f5e0b249bd6f7e3d50032ee5e10350af3417b","side":"left"},{"sibling":"fb2dc740a0aca5703cdae1a53eac87293476f21d0ce588b6fb74e62e112dd6a1","side":"left"},{"sibling":"b23e05f5a3c9defe23316ce264fed0315481fd5b7e3632665405d3a829b5ff76","side":"right"},{"sibling":"9abe7beed823fcb4fca86168a937bdf567afb433b776352858b68322288bbf2a","side":"right"},{"sibling":"5d10c089cc50333cc6f5ec8f5c37b251f9cdd4252a9604bb46ec83ac720abdd9","side":"right"},{"sibling":"b4e8a5af3a9fdc4bb815270cd541ee4baf09fb1d9e2cccd75c7346558e1f1e4c","side":"left"},{"sibling":"cfb460164a914d1f96a36aa17124b45bb5417829d2adbe5ca48375dbd842ec44","side":"left"},{"sibling":"a84ebc8e894a9893ee34d1afc942d15f28243b926f1e5f9d7f10a3de1e795262","side":"left"},{"sibling":"f8f6bd9da448fa097e2115b71146f61691d9f8807aca291c87c633192a7224e9","side":"left"},{"sibling":"2dca509b3eb767a47cf215d4315f230ce9103a76264412008ae23a349b519ef1","side":"left"},{"sibling":"24d1bb4b13e0e46131b27b70a48e65fcf4e2e14b95e3bb83ade821e9df530f6b","side":"left"},{"sibling":"422bcf7e281ca3a607f3726a5e6b8fabdb85e8b32199b4a86356998e260a0b34","side":"right"},{"sibling":"54a99163a4a62374c3ca6fb46294222f1d4b1a9d0b636e27256b0e093e98239a","side":"right"},{"sibling":"c300cf0154c136afc09b1702a0be98f4ba5b6dc5cf57e8cc714ec1eaf4196eff","side":"left"},{"sibling":"d841ad93efda0869e5eb97678f348f03f5caab4353e05ff4bf18f47fb945b822","side":"left"}]},"schema":"crovia.axiom_proof.v1","seal":{"first_collector_run_id":"","first_receipt_hash":"","jsonl_path":"/opt/crovia/substrate/axiom_ledger.jsonl","key_id":"430895f101d38164","last_collector_run_id":"","last_receipt_hash":"","leaf_count":213053,"merkle_root":"19d104b92c4d7299881c447fb8422611fc9cb8615d37a538959e34a2da7ef55f","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","run_id":"hourly_json_retrofit_20260604T053701Z","schema":"crovia.seal.v1","seal_family_version":"crovia-seal-family/1","seal_kind":"substrate_batch","sealed_at":"2026-06-04T05:37:49Z","sig_algorithm":"ed25519","signature":"630748e88645187aa3b4d4cb8c872cc146180d0301e4c6656f15f99081d7776432715cea2a997b32b7b3a5216f215d19c1b536c0b093100ec843fa0bd65f2101","signer_version":"1.1.0"},"trust_root":{"key_id":"430895f101d38164","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","signature_algorithm":"ed25519","url":"/registry/canon/TRUST_ROOT.md"},"verifier":{"spec":"/registry/canon/AXIOM_RECEIPT_v1.md","url":"/v/axm_635a5b0c4183d7cd5aa33a2141db19633c90d6a597626bd6e9137b28f7ced1f3"}}